Summary

Persistence Market Research has recently published a detailed report on the global stretch marks treatment market. The report provides an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, delivering comprehensive insights into the market structure.

Key Insights:

• Stretch Marks Treatment Market Size (2024E): USD 2.9 Billion
• Projected Market Value (2033F): USD 4.6 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 5.3%

Stretch Marks Treatment Market - Report Scope:

Stretch marks, also known as striae or striae distensae, are a common skin condition resulting from the rapid stretching of the skin. The stretch marks treatment market encompasses various therapeutic options, including topical treatments, laser therapies, and surgical interventions. These treatments aim to reduce the appearance of stretch marks and enhance skin texture. The market caters to a diverse customer base, including individuals seeking cosmetic improvements, healthcare providers offering specialized treatments, and aesthetic clinics providing advanced solutions. Market growth is driven by increasing awareness of skin aesthetics, a rising prevalence of stretch marks due to lifestyle and hormonal changes, and advancements in treatment technologies.

Market Growth Drivers:

Several key factors drive the global stretch marks treatment market, including:

Growing Awareness: Rising awareness about effective treatment options.
Prevalence Factors: Increasing instances of stretch marks due to pregnancy, rapid weight gain, and puberty.
Technological Advancements: Development of non-invasive laser treatments and enhanced topical formulations improving efficacy and patient comfort.
Aesthetic Emphasis: Growing emphasis on aesthetic enhancements and cosmetic procedures.
Disposable Income: Rise in disposable incomes and the trend toward personalized skincare solutions.
Market Restraints:

Despite promising growth, the stretch marks treatment market faces several challenges:

Cost and Accessibility: High costs of advanced treatments like laser therapies and surgical interventions may limit accessibility for some individuals.
Treatment Variability: Effectiveness can vary based on skin types and severity of stretch marks, affecting patient satisfaction.
Regulatory and Research Challenges: Issues related to regulatory compliance and the need for ongoing research to validate treatment efficacy and safety.

Market Opportunities:

The market offers significant growth opportunities driven by:

Technological Innovations: Integration of new technologies such as radiofrequency and ultrasound-based treatments.
Personalized Skincare: Increased focus on personalized skincare solutions and minimally invasive procedures.
Strategic Partnerships: Opportunities for market players through strategic partnerships, investment in R&D, and the introduction of affordable, effective treatments.

Key Questions Answered in the Report:

• What are the primary factors driving global growth in the stretch marks treatment market?
• Which treatment types and applications are seeing adoption across different patient demographics?
• How are technological advancements influencing the competitive landscape of the stretch marks treatment market?
• Who are the key players in the stretch marks treatment market, and what strategies are they using to stay competitive?
• What are the emerging trends and future prospects in the global stretch marks treatment market?

Competitive Intelligence and Business Strategy:

Leading companies in the stretch marks treatment market, such as Allergan PLC, Revance Therapeutics, Inc., and Syneron Candela, focus on innovation, product differentiation, and strategic partnerships. These companies invest in R&D to develop advanced treatment solutions, including novel topical agents, laser devices, and minimally invasive procedures. Collaborations with dermatologists, aesthetic clinics, and research institutions enhance market access and promote technology adoption. Emphasis on clinical research, evidence-based practice, and patient education supports market growth and improves patient outcomes.

Key Companies Profiled:

• Weleda
• Clarins
• basq NYC
• Body Merry
• Himalaya Global Holdings Ltd.
• Stratpharma AG (Stratpharma Inc.)
• Browne Drug Co., Inc. (Palmer’s)
• Mederma (HRA Pharma)
• Givaudan SA
• NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
• Bio-Oil (Union Swiss (Pty) Ltd)
• Merz Pharma
• Dermaclara
• Unilever

Key Segments of Stretch Marks Treatment Industry Research

By Treatment:
• Topical Medications
• Procedural Treatments

By Stretch Mark Type:
• Striae atrophicans (Thinned Skin)
• Striae gravidarum (Post Pregnancy)
• Striae distensae (Stretched Skin)
• striae rubrae (Red)
• Striae albae (White)
• Striae nigra (Black)
• Striae caerulea (Dark Blue)

By End User:
• Hospitals
• Dermatology Clinics
• Aesthetic Clinics
• Wellness and Spa Centers
• Home Care Settings

By Region:
• North America
• Latin America
• Europe Stretch
• South Asia Stretch
• East Asia Stretch
• Oceania Stretch
• The Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Treatment Type Innovation / Development Trends
4. Key Success Factors
4.1. Porter’s Analysis
4.2. PESTEL Analysis
4.3. Dermatologists/Cosmetic Surgeons, Key Country
4.4. Dermatology/Cosmetic Surgery Clinics, Key Country
4.5. Number of Aesthetic Procedures, By Region
4.6. Number of Pregnancy, By Region
4.7. Payer Mix Analysis
4.8. Promotional Strategies, By Key Players
4.9. Healthcare Reimbursement and Financing Structure
4.10. Regulatory Scenario
4.11. Parent Market Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Life Expectancy Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Increasing Cases of Pregnancy
5.2.2. Rising Disposable Per Capita Income
5.2.3. Adoption of Aesthetic Treatments
5.2.4. Changes in Lifestyle
5.2.5. Shift from Invasive to Non-invasive Laser Therapies
5.2.6. Presence of Highly Skilled Workforce
5.2.7. Media Coverage and Awareness from Celebrities
5.2.8. New/Improved Product Launches
5.2.9. Growing Investment in Healthcare Expenditure
5.2.10. Mergers and Acquisitions
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis – Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. By Treatment Type
6.1.2. By Stretch Marks Type
6.1.3. BY End User
6.1.4. By Region
6.2. 2023 Market Scenario
7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Treatment Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Treatment Type, 2019-2023
8.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Treatment Type, 2024-2033
8.3.1. Topical Medications
8.3.1.1. Gels
8.3.1.2. Creams
8.3.1.3. Oils/Serums
8.3.2. Procedural Treatments
8.3.2.1. Radiofrequency Therapy
8.3.2.2. Nonablative Laser Fractional Resurfacing
8.3.2.3. Ablative Laser Resurfacing
8.3.2.4. Infrared Devices/Radiations
8.3.2.5. Dermabrasion
8.3.2.6. Chemical Peel
8.4. Market Attractiveness Analysis By Treatment Type
9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Stretch Marks Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Stretch Marks Type, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Stretch Marks Type, 2024-2033
9.3.1. Striae Atrophicans (Thinned Skin)
9.3.2. Striae Gravidarum (Post Pregnancy)
9.3.3. Striae Distensae (Stretched Skin)
9.3.4. Striae Rubrae (Red)
9.3.5. Striae Albae (White)
9.3.6. Striae Nigra (Black)
9.3.7. Striae Caerulea (Dark Blue)
9.4. Market Attractiveness Analysis By Stretch Marks Type
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
10.3.1. Hospitals
10.3.2. Dermatology Clinics
10.3.3. Aesthetic Clinics
10.3.4. Wellness and Spa Centers
10.3.5. Home Care Settings
10.4. Market Attractiveness Analysis By End User
11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
11.3. Current Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. South Asia
11.3.5. East Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2019-2023 and Forecast 2024-2033
12.1. Introduction
12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
12.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Treatment Type
12.3.3. By Stretch Marks Type
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Treatment Type
12.4.3. By Stretch Marks Type
12.4.4. By End User
12.5. Country Level Analysis & Forecast
12.5.1. U.S. Market Analysis
12.5.1.1. .Introduction
12.5.1.2. Market Analysis and Forecast by Market Taxonomy
12.5.1.2.1. By Treatment Type
12.5.1.2.2. By Stretch Marks Type
12.5.1.2.3. By End User
12.5.2. Canada Market Analysis
12.5.2.1. Introduction
12.5.2.2. Market Analysis and Forecast by Market Taxonomy
12.5.2.2.1. By Treatment Type
12.5.2.2.2. By Stretch Marks Type
12.5.2.2.3. By End User
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
13.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Stretch Marks Type
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Treatment Type
13.4.3. By Stretch Marks Type
13.4.4. By End User
13.5. Country Level Analysis & Forecast
13.5.1. Brazil Market Analysis
13.5.1.1. .Introduction
13.5.1.2. Market Analysis and Forecast by Market Taxonomy
13.5.1.2.1. By Treatment Type
13.5.1.2.2. By Stretch Marks Type
13.5.1.2.3. By End User
13.5.2. Mexico Market Analysis
13.5.2.1. Introduction
13.5.2.2. Market Analysis and Forecast by Market Taxonomy
13.5.2.2.1. By Treatment Type
13.5.2.2.2. By Stretch Marks Type
13.5.2.2.3. By End User
13.5.3. Argentina Market Analysis
13.5.3.1. Introduction
13.5.3.2. Market Analysis and Forecast by Market Taxonomy
13.5.3.2.1. By Treatment Type
13.5.3.2.2. By Stretch Marks Type
13.5.3.2.3. By End User
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. Europe Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
14.3. Market Size (US$ Bn) and Volume (Units) Forecast, By Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. France
14.3.1.3. Italy
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. Russia
14.3.1.7. BENELUX
14.3.1.8. Nordic Countries
14.3.1.9. Rest of Europe
14.3.2. By Treatment Type
14.3.3. By Stretch Marks Type
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Treatment Type
14.4.3. By Stretch Marks Type
14.4.4. By End User
14.5. Country Level Analysis & Forecast
14.5.1. Germany Market Analysis
14.5.1.1. .Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Treatment Type
14.5.1.2.2. By Stretch Marks Type
14.5.1.2.3. By End User
14.5.2. France Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Treatment Type
14.5.2.2.2. By Stretch Marks Type
14.5.2.2.3. By End User
14.5.3. Italy Market Analysis
14.5.3.1. Introduction
14.5.3.2. Market Analysis and Forecast by Market Taxonomy
14.5.3.2.1. By Treatment Type
14.5.3.2.2. By Stretch Marks Type
14.5.3.2.3. By End User
14.5.4. U.K. Market Analysis
14.5.4.1. .Introduction
14.5.4.2. Market Analysis and Forecast by Market Taxonomy
14.5.4.2.1. By Treatment Type
14.5.4.2.2. By Stretch Marks Type
14.5.4.2.3. By End User
14.5.5. Spain Market Analysis
14.5.5.1. .Introduction
14.5.5.2. Market Analysis and Forecast by Market Taxonomy
14.5.5.2.1. By Treatment Type
14.5.5.2.2. By Stretch Marks Type
14.5.5.2.3. By End User
14.5.6. Russia Market Analysis
14.5.6.1. .Introduction
14.5.6.2. Market Analysis and Forecast by Market Taxonomy
14.5.6.2.1. By Treatment Type
14.5.6.2.2. By Stretch Marks Type
14.5.6.2.3. By End User
14.5.7. Nordic Countries Market Analysis
14.5.7.1. .Introduction
14.5.7.2. Market Analysis and Forecast by Market Taxonomy
14.5.7.2.1. By Treatment Type
14.5.7.2.2. By Stretch Marks Type
14.5.7.2.3. By End User
14.5.8. BENELUX Market Analysis
14.5.8.1. .Introduction
14.5.8.2. Market Analysis and Forecast by Market Taxonomy
14.5.8.2.1. By Treatment Type
14.5.8.2.2. By Stretch Marks Type
14.5.8.2.3. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
15.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Treatment Type
15.3.3. By Stretch Marks Type
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Treatment Type
15.4.3. By Stretch Marks Type
15.4.4. By End User
15.5. Country Level Analysis & Forecast
15.5.1. India Market Analysis
15.5.1.1. .Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Treatment Type
15.5.1.2.2. By Stretch Marks Type
15.5.1.2.3. By End User
15.5.2. Thailand Market Analysis
15.5.2.1. .Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Treatment Type
15.5.2.2.2. By Stretch Marks Type
15.5.2.2.3. By End User
15.5.3. Indonesia Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Treatment Type
15.5.3.2.2. By Stretch Marks Type
15.5.3.2.3. By End User
15.5.4. Malaysia Market Analysis
15.5.4.1. Introduction
15.5.4.2. Market Analysis and Forecast by Market Taxonomy
15.5.4.2.1. By Treatment Type
15.5.4.2.2. By Stretch Marks Type
15.5.4.2.3. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
16.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Treatment Type
16.3.3. By Stretch Marks Type
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Treatment Type
16.4.3. By Stretch Marks Type
16.4.4. By End User
16.5. Country Level Analysis & Forecast
16.5.1. China Market Analysis
16.5.1.1. .Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Treatment Type
16.5.1.2.2. By Stretch Marks Type
16.5.1.2.3. By End User
16.5.2. Japan Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Treatment Type
16.5.2.2.2. By Stretch Marks Type
16.5.2.2.3. By End User
16.5.3. South Korea Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Treatment Type
16.5.3.2.2. By Stretch Marks Type
16.5.3.2.3. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Oceania Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
17.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Treatment Type
17.3.3. By Stretch Marks Type
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Treatment Type
17.4.3. By Stretch Marks Type
17.4.4. By End User
17.5. Country Level Analysis & Forecast
17.5.1. Australia Market Analysis
17.5.1.1. .Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Treatment Type
17.5.1.2.2. By Stretch Marks Type
17.5.1.2.3. By End User
17.5.2. New Zealand Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Treatment Type
17.5.2.2.2. By Stretch Marks Type
17.5.2.2.3. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
18.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Türkiye
18.3.1.3. Northern Africa
18.3.1.4. South Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Treatment Type
18.3.3. By Stretch Marks Type
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Treatment Type
18.4.3. By Stretch Marks Type
18.4.4. By End User
18.5. Country Level Analysis & Forecast
18.5.1. GCC Countries Market Analysis
18.5.1.1. .Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Treatment Type
18.5.1.2.2. By Stretch Marks Type
18.5.1.2.3. By End User
18.5.2. Türkiye Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Treatment Type
18.5.2.2.2. By Stretch Marks Type
18.5.2.2.3. By End User
18.5.3. Northern Africa Market Analysis
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Treatment Type
18.5.3.2.2. By Stretch Marks Type
18.5.3.2.3. By End User
18.5.4. South Africa Market Analysis
18.5.4.1. Introduction
18.5.4.2. Market Analysis and Forecast by Market Taxonomy
18.5.4.2.1. By Treatment Type
18.5.4.2.2. By Stretch Marks Type
18.5.4.2.3. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Weleda
20.3.1.1. Overview
20.3.1.2. Treatment Type Portfolio
20.3.1.3. Profitability by Market Segments (Treatment Type/Region)
20.3.1.4. Sales Footprint
20.3.1.5. Strategy Overview
20.3.2. Clarins
20.3.2.1. Overview
20.3.2.2. Treatment Type Portfolio
20.3.2.3. Profitability by Market Segments (Treatment Type/Region)
20.3.2.4. Sales Footprint
20.3.2.5. Strategy Overview
20.3.3. basq NYC
20.3.3.1. Overview
20.3.3.2. Treatment Type Portfolio
20.3.3.3. Profitability by Market Segments (Treatment Type/Region)
20.3.3.4. Sales Footprint
20.3.3.5. Strategy Overview
20.3.4. Body Merry
20.3.4.1. Overview
20.3.4.2. Treatment Type Portfolio
20.3.4.3. Profitability by Market Segments (Treatment Type/Region)
20.3.4.4. Sales Footprint
20.3.4.5. Strategy Overview
20.3.5. Himalaya Global Holdings Ltd.
20.3.5.1. Overview
20.3.5.2. Treatment Type Portfolio
20.3.5.3. Profitability by Market Segments (Treatment Type/Region)
20.3.5.4. Sales Footprint
20.3.5.5. Strategy Overview
20.3.6. Stratpharma AG (Stratpharma Inc.)
20.3.6.1. Overview
20.3.6.2. Treatment Type Portfolio
20.3.6.3. Profitability by Market Segments (Treatment Type/Region)
20.3.6.4. Sales Footprint
20.3.6.5. Strategy Overview
20.3.7. Browne Drug Co., Inc. (Palmer’s)
20.3.7.1. Overview
20.3.7.2. Treatment Type Portfolio
20.3.7.3. Profitability by Market Segments (Treatment Type/Region)
20.3.7.4. Sales Footprint
20.3.7.5. Strategy Overview
20.3.8. Mederma (HRA Pharma)
20.3.8.1. Overview
20.3.8.2. Treatment Type Portfolio
20.3.8.3. Profitability by Market Segments (Treatment Type/Region)
20.3.8.4. Sales Footprint
20.3.8.5. Strategy Overview
20.3.9. Givaudan SA
20.3.9.1. Overview
20.3.9.2. Treatment Type Portfolio
20.3.9.3. Profitability by Market Segments (Treatment Type/Region)
20.3.9.4. Sales Footprint
20.3.9.5. Strategy Overview
20.3.10. NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
20.3.10.1. Overview
20.3.10.2. Treatment Type Portfolio
20.3.10.3. Profitability by Market Segments (Treatment Type/Region)
20.3.10.4. Sales Footprint
20.3.10.5. Strategy Overview
20.3.11. Bio-Oil (Union Swiss (Pty) Ltd)
20.3.11.1. Overview
20.3.11.2. Treatment Type Portfolio
20.3.11.3. Profitability by Market Segments (Treatment Type/Region)
20.3.11.4. Sales Footprint
20.3.11.5. Strategy Overview
20.3.12. Merz Pharma
20.3.12.1. Overview
20.3.12.2. Treatment Type Portfolio
20.3.12.3. Profitability by Market Segments (Treatment Type/Region)
20.3.12.4. Sales Footprint
20.3.12.5. Strategy Overview
20.3.13. Dermaclara
20.3.13.1. Overview
20.3.13.2. Treatment Type Portfolio
20.3.13.3. Profitability by Market Segments (Treatment Type/Region)
20.3.13.4. Sales Footprint
20.3.13.5. Strategy Overview
20.3.14. Unilever
20.3.14.1. Overview
20.3.14.2. Treatment Type Portfolio
20.3.14.3. Profitability by Market Segments (Treatment Type/Region)
20.3.14.4. Sales Footprint
20.3.14.5. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology